The Evidence-based Pharmacoeconomic Evaluation of the Effect of Rosuvastatin Calcium and Atorvastatin Calcium on the Regulation of Lipid in Patients with Coronary Heart Disease

ZHANG Xiao-long; SHEN Ya-bing

doi:10.3969/j.issn.1001-568X.2018.08.0020

Home>Articles>The Evidence-based Pharmacoeconomic Evaluation of the Effect of Rosuvastatin Calcium and Atorvastatin Calcium on the Regulation of Lipid in Patients with Coronary Heart Disease

DOI: 10.3969/j.issn.1001-568X.2018.08.0020

The Evidence-based Pharmacoeconomic Evaluation of the Effect of Rosuvastatin Calcium and Atorvastatin Calcium on the Regulation of Lipid in Patients with Coronary Heart Disease

ZHANG Xiao-long

SHEN Ya-bing

Machine-generated Keywords：

Publication Date：2018-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 52-54 )

Chinese Primary Health Care

ISSN：1001-568X

Year, Vol.(Issue)：2018,32(8)